Tweets by FSCDR's 17th Annual SCD Research and Educational Symposium & 46th Nat'l SCD Scientific Meeting

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Stream

NOTE: All events are in Eastern Daylight Time Zone. Please visit your Symposium Profile to verify your time zone. We recommend displaying all times in the event time zone.

Type here to filter the list

Sunday, Jun 18th
3:45 PM – 4:00 PM East Coast USA Time
Efficacy and Safety of Exagamglogene Autotemcel for Sickle Cell Disease
Location: Grand Salon E
Speaker: William Hobbs – Vertex Pharmaceuticals, Inc
Author: Haydar Frangoul, MD – Sarah Cannon Center for Blood Cancer at The Children’s Hospital at TriStar Centennial
Author: Franco Locatelli, MD – IRCCS, Ospedale Pediatrico Bambino Gesù Rome, Catholic University of the Sacred Heart
Author: Akshay Sharma, MD – Bone Marrow Transplantation and Cellular Therapy, St. Jude Children’s Research Hospital
Author: Monica Bhatia, MD – Columbia University Irving Medical Center, New York – Presbyterian-Morgan Stanley Children’s Hospital
Author: Markus Y. Mapara, MD – Columbia University
Author: Lyndsay Molinari, MD – Methodist Children’s Hospital
Author: Donna Wall, MD – The Hospital for Sick Children/University of Toronto
Author: Robert Liem, MD – Ann & Robert H. Lurie Children's Hospital of Chicago
Author: Paul Telfer, MD – Barts Health NHS Trust
Author: Ami Shah, MD – Stanford University
Author: Marina Cavazzana, MD – Necker-Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), University of Paris
Author: Selim Corbacioglu, MD – University of Regensburg
Author: Damiano Rondelli, MD – University of Illinois at Chicago
Author: Roland Meisel, MD – Heinrich-Heine-University
Author: Laurence Dedeken, MD – Hopital Universitaire des Enfants Reine Fabiola
Author: Stephan Lobitz, MD – Gemeinschaftsklinikum Mittelrhein
Author: Mariane de Montalembert, MD, PhD – Sickle Cell Center, Necker-Enfants Malades Hospital
Author: Martin Steinberg, MD – Boston University
Author: Mark C. Walters, MD – UCSF Benioff Children's Hospital Oakland
Author: Suzan Imren, MD – Vertex Pharmaceuticals, Inc
Author: Daoyuan Shi, n/a – Vertex Pharmaceuticals, Inc
Author: Laura Bower, n/a – Vertex Pharmaceuticals
Author: Christopher Simard, n/a – Vertex Pharmaceuticals, Inc
Author: Lanju Zhang, n/a – Vertex
Author: Phuong Khanh Morrow, MD – CRISPR Therapeutics
Corresponding Author: William Hobbs – Vertex Pharmaceuticals, Inc
Author: William Hobbs – Vertex Pharmaceuticals, Inc
Author: Stephan Grupp, MD – Children's Hospital of Philadelphia
Investigational and Therapeutic Drugs
Sunday, Jun 18th
4:15 PM – 4:30 PM East Coast USA Time
Hibiscus-Kids: A Single Arm, Open Label, Phase 1/2 Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients with Sickle Cell Disease
Location: Grand Salon E
Speaker: Leila Jerome Clay, MD (she/her/hers) – Novo Nordisk Inc.
First Author: Leila Jerome Clay, MD (she/her/hers) – Novo Nordisk Inc.
Author: Julie Kanter, MD – Division of Hematology and Oncology, University of Alabama Birmingham
Author: Miguel R. Abboud, MD – American University of Beirut Medical Center, Beirut, Lebanon
Author: Eric Wu, PhD – NOVO NORDISK A/S
Author: Leila Jerome Clay, MD (she/her/hers) – Novo Nordisk Inc.
Corresponding Author: Adlette Inati, MD, FAAP – Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Department of Pediatrics and Adolescent Medicine, Beirut, Lebanon
Author: Adlette Inati, MD, FAAP – Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Department of Pediatrics and Adolescent Medicine, Beirut, Lebanon
Investigational and Therapeutic Drugs